Trial · NCT07912853
Integration of Imaging, Molecular, Pathological, and Clinical Outcome Data in Hepatocellular Carcinoma.
NCT07912853, Not yet recruiting, West China Hospital
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Integration of Imaging, Molecular, Pathological, and Clinical Outcome Data in Hepatocellular Carcinoma. Trials, record NCT07912853. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07912853
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Integration of Imaging, Molecular, Pathological, and Clinical Outcome Data in Hepatocellular Carcinoma.
- NCT number
- NCT07912853
- Status
- Not yet recruiting
- Enrollment
- 380 participants, estimated
- Lead sponsor
- West China Hospital
- Conditions
- Resectable Hepatocellular Carcinoma (HCC)
- Interventions
- Resection
- First posted
- 2026-11-03
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Recurrence-free Survival (RFS) | From resection to the first documented recurrence or death from any cause, whichever occurs first, assessed up to 3 years. | Recurrence-free survival is defined as the time from resection of HCC to the first documented tumor recurrence or death from any cause, whichever occurs first. Participants without recurrence or death will be censored at the date of their last follow-up. Characteristics of recurrence, including but not limited to recurrence location, proximity to the surgical margin, tumor size, and number of recurrent lesions, will be collected at the time of recurrence. |
| Secondary | Overall Survival (OS) | From resection to death from any cause, assessed up to 3 years | Overall survival is defined as the time from resection of HCC to death from any cause. Participants who are alive at the last follow-up will be censored at the date of last contact. The cause of death will be adjudicated and classified as tumor-related or non-tumor-related. |
| Secondary | Time to recurrence (TTR) | From resection to the first documented recurrence, assessed up to 3 years. | Time to recurrence is defined as the time from resection of HCC to the first documented tumor recurrence. Participants without recurrence will be censored at the date of their last follow-up. Characteristics of recurrence, including recurrence location, proximity to the surgical margin, tumor size, and number of recurrent lesions, will be collected at the time of recurrence. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07912853
GET https://conductscience.org/api/trials/v1/NCT07912853/registered